“2020 proved a challenging year for most, and despite the hardships, HACARUS managed to continue its stride – this is all thanks to the continued support of our partners, customers and employees, whom we are deeply grateful towards. Compared to a year ago, we are now able to offer more products and services, and are even better positioned to help clients achieve their AI goals – I look forward to continuing our work in 2021” Said Kenshin Fujiwara, CEO and Founder.
In 2020, we have had some very exciting projects with our partners – from combining HACARUS’ expertise in AI powered medical imaging analysis with Mitsubishi Electric’s advanced industrial robots, to starting a joint development projects with firms such as Osaka Gas and DS Pharma Animal Health.
This has also been a year of massive growth – HACARUS Series B financing round was closed with 1.3 Billion Yen to date – this will allow us to further strengthen R&D in materials informatics and drug discovery, and fuel Domestic & Global Business Expansion.
We’ve also been quite successful in hiring – as a result, the number of staffs has increased by 60% compared to last year! With the opening of a new R&D center, we are now more ready than ever to handle customer requests. (We have multiple job openings – please send your application here)
We truly appreciate your continued support. We will continue to do our best to be your best AI solutions partner – in fact, HACARUS has some very exciting announcements coming up at the beginning of 2021! We wish you a wonderful holiday season, and an excellent year ahead.